Cargando…
Repression of Smad4 by miR-205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines
Autores principales: | Zeng, Yuanyuan, Zhu, Jianjie, Shen, Dan, Qin, Hualong, Lei, Zhe, Li, Wei, Huang, Jian-An, Liu, Zeyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864006/ https://www.ncbi.nlm.nih.gov/pubmed/33491753 http://dx.doi.org/10.3892/ijo.2021.5166 |
Ejemplares similares
-
MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo
por: Zeng, Yuanyuan, et al.
Publicado: (2016) -
[Corrigendum] Thymoquinone inhibits epithelial‑mesenchymal transition in prostate cancer cells by negatively regulating the TGF‑β/Smad2/3 signaling pathway
por: Kou, Bo, et al.
Publicado: (2023) -
[Corrigendum] MicroRNA-133b targets TGFβ receptor I to inhibit TGF-β-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-β/SMAD pathway in breast cancer
por: Wang, Shengjie, et al.
Publicado: (2023) -
Repression of Smad4 by MicroRNA-1285 moderates TGF-β-induced epithelial–mesenchymal transition in proliferative vitreoretinopathy
por: Pao, Shu-I, et al.
Publicado: (2021) -
Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]
por: Bu, Wenhuan, et al.
Publicado: (2019)